Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.70    0.40 (1.24%)
Bid:
32.50
Ask:
33.00
Spread: 0.50 (1.538%)
Market Cap: £24.01m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

12 Oct 2018 07:00

RNS Number : 8202D
Carclo plc
12 October 2018
 

Carclo plc ("the Group")

Trading update - full year expectations unchanged

Trading in the first half was below the Board's expectations due to underperformance at Technical Plastics.

In Technical Plastics, three new medical programmes were delayed by customers in the period but all entered production successfully towards the end of the first half of the year and this, together with planned new tooling programmes, support the expected stronger second half performance. The implementation of our operational improvement programme has delivered a number of price increases, efficiency opportunities and cost savings across the division, the benefit of which will positively impact margins in the second half of the year and beyond.

In the LED Division, Wipac has continued to be successful in winning new programmes, including nomination for two mid-volume electric vehicles, leading to a healthy level of design and development contract profits. Production demand has been solid. All of the current year's planned new vehicle production programmes launched in the first half and this resulted in higher than anticipated manufacturing costs being incurred during launch. Associated margins are expected to improve in the second half as production accelerates and initial start-up inefficiencies are eliminated.

The smaller Aerospace Division performed slightly ahead of expectations as a result of higher margins and tight control over costs.

The Board's expectations for the year ending 31 March 2019 remain unchanged, with results weighted towards the second half of the year, as expected. This reflects the full effect of the new programmes, expected customer timings on projects and the anticipated improvement in margins at Wipac in addition to cost saving initiatives, ramp up in production volumes and expected higher design and tooling profits in Technical Plastics.

The Group will announce its interim results for the period ended 30 September 2018 on 13 November 2018.

For further information please contact:

Carclo plc

Chris Malley, Chief Executive 01924 268040

Sarah Matthews-DeMers, Group Finance Director

 

Peel Hunt LLP (Corporate broker)

Justin Jones 0207 418 8900

Sam Cann

 

Weber Shandwick Financial (Financial PR)

Nick Oborne 020 7067 0700

 

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSAIELLLIT
Date   Source Headline
14th Feb 20083:30 pmRNSHolding(s) in Company
6th Feb 20087:00 amRNSInterim Management Statement
29th Nov 20071:20 pmRNSDirector/PDMR Shareholding
27th Nov 20077:00 amRNSInterim Results
31st Oct 200710:18 amRNSNotice of Results
3rd Oct 20072:45 pmRNSAdditional Listing
1st Oct 20077:01 amRNSAcquisition & Trading Update
7th Sep 200711:24 amRNSResult of AGM
15th Aug 20077:01 amRNSInterim Management Statement
10th Jul 20072:14 pmRNSDirector/PDMR Shareholding
14th Jun 200712:14 pmRNSDirector/PDMR Shareholding
12th Jun 20077:01 amRNSFinal Results
16th May 20079:59 amRNSNotice of Results
5th Apr 20077:01 amRNSTrading Update
9th Mar 20077:01 amRNSJoint Venture Agreement
9th Mar 20077:01 amRNSJoint Venture Agreement
15th Feb 20072:53 pmRNSDisposal completion
30th Jan 20074:14 pmRNSTotal Voting Rights
21st Dec 200611:12 amRNSTotal Voting Rights
5th Dec 20067:00 amRNSInterim Results
1st Dec 200612:14 pmRNSProperty Disposals
6th Nov 20067:01 amRNSNotice of Results
15th Sep 200612:11 pmRNSDirector/PDMR Shareholding
15th Sep 200612:05 pmRNSDirector/PDMR Shareholding
7th Sep 20067:02 amRNSAGM Statement
27th Jul 20063:11 pmRNSDirector/PDMR Shareholding
14th Jun 20063:00 pmRNSDirector/PDMR Shareholding
12th Jun 20067:00 amRNSFinal Results
18th May 20064:33 pmRNSNotice of Results
12th May 20064:24 pmRNSResult of EGM - Disposal
11th May 200610:58 amRNSResult of EGM
25th Apr 20066:24 pmRNSPosting of Circular
25th Apr 20067:03 amRNSDisposal
4th Apr 20067:01 amRNSTrading Update
9th Feb 200612:01 pmRNSFurther re Board Appointments
3rd Jan 20067:01 amRNSFurther re Board Appointments
7th Dec 200510:11 amRNSDirector/PDMR Shareholding
10th Nov 20053:46 pmRNSNotice of Results
31st Oct 200512:21 pmRNSReduction of Share Premium
10th Oct 200511:53 amRNSTrading Update
4th Oct 20057:00 amRNSRestatement under IFRS
27th Sep 20051:52 pmRNSDirector/PDMR Shareholding
27th Sep 20051:38 pmRNSDirector/PDMR Shareholding
1st Sep 20053:15 pmRNSAGM Statement
29th Jul 20054:37 pmRNSDirector/PDMR Shareholding
29th Jul 200510:08 amRNSDirector/PDMR Shareholding
28th Jul 200512:36 pmRNSDirector/PDMR Shareholding
28th Jul 200511:28 amRNSAcquisition and Placing
23rd Jun 20057:01 amRNSCompletion of Disposal
13th Jun 200511:52 amRNSResult of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.